FDA recall D-0040-2025

Staska Pharmaceuticals, Inc. · Class I · drug

Product

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

Reason for recall

Presence of Particulate Matter: Presence of glass particulates.

Distribution

Nationwide in the USA

Key facts

Status: Terminated
Initiation date: 2024-09-30
Report date: 2024-11-13
Termination date: 2025-08-05
Voluntary/Mandated: Voluntary: Firm initiated
Location: Bennet, NE, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0040-2025